Edition:
United States

Opexa Therapeutics Inc (OPXA.O)

OPXA.O on Consolidated Issue listed on NASDAQ Capital Market

3.17USD
30 Sep 2016
Change (% chg)

$-0.07 (-2.16%)
Prev Close
$3.24
Open
$3.20
Day's High
$3.28
Day's Low
$3.15
Volume
36,336
Avg. Vol
162,195
52-wk High
$5.10
52-wk Low
$1.69

OPXA.O

Chart for OPXA.O

About

Opexa Therapeutics, Inc. (Opexa) is a biopharmaceutical company. The Company is engaged in the development of a personalized immunotherapy with the potential to treat various illnesses, including multiple sclerosis (MS), as well as other autoimmune diseases, such as neuromyelitis optica (NMO). These therapies are based on its... (more)

Overall

Beta: 1.30
Market Cap(Mil.): $22.84
Shares Outstanding(Mil.): 7.05
Dividend: --
Yield (%): --

Financials

  OPXA.O Industry Sector
P/E (TTM): -- 43.83 36.83
EPS (TTM): -1.37 -- --
ROI: -91.69 -0.29 13.93
ROE: -98.65 -2.99 14.84

BRIEF-Opexa Therapeutics reports Q2 loss per share $0.30

* Opexa Therapeutics reports second quarter 2016 financial results and provides corporate update

Aug 11 2016

BRIEF-Opexa Therapeutics Q1 loss per share $0.31

* Opexa therapeutics reports first quarter 2016 financial results and provides corporate update

May 12 2016

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.